Consensus Recommendations From the Children's Oncology Group Nursing Discipline's State of the Science Symposium: Symptom Assessment During Childhood Cancer Treatment
- PMID: 31307318
- PMCID: PMC6949956
- DOI: 10.1177/1043454219854983
Consensus Recommendations From the Children's Oncology Group Nursing Discipline's State of the Science Symposium: Symptom Assessment During Childhood Cancer Treatment
Abstract
Background: Recognizing and addressing illness-related distress has long been a priority for pediatric oncology nurses and the Children's Oncology Group. Although symptoms are known to be highly prevalent during treatment for childhood cancer, there is currently no guidance for how often symptoms should be assessed, which symptoms should be prioritized for assessment, and how the data should be collected. Methods: The Nursing Discipline, within Children's Oncology Group, hosted a one-day Interprofessional seminar titled "Symptom Assessment During Childhood Cancer Treatment: State of the Science Symposium." Following the symposium, an expert panel was assembled to review all available evidence, including information presented and collected during the symposium. Consensus-building discussions were held to identify common themes and to produce recommendations for clinical practice. Results: Four recommendations emerged including (1) the identification of priority "core" symptoms for assessment; (2) inclusion of the child's voice through self-report, when possible; (3) consistent documentation and communication of symptom assessment results; and (4) implementation of patient/family education related to symptoms. Discussion: Symptom recognition, through appropriate assessment, is the first step in symptom management. The goal for developing and sharing these recommendations is to promote consistent and comparable clinical practice across institutions in regard to symptom assessment during childhood cancer therapy. Integration of these recommendations will set the stage for future studies related to the frequency of symptoms across disease groups, projection of anticipated symptom trajectories, development of evidence-based teaching tools for common symptoms, and evaluation of patient outcomes with enhanced symptom assessment and management.
Keywords: Children’s Oncology Group; consensus; pediatric oncology; symptom science.
Conflict of interest statement
Similar articles
-
Perspectives of Childhood Cancer Symptom-Related Distress: Results of the State of the Science Survey.J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):287-293. doi: 10.1177/1043454219858608. J Pediatr Oncol Nurs. 2019. PMID: 31307322 Free PMC article.
-
Patient/Family Education for Newly Diagnosed Pediatric Oncology Patients.J Pediatr Oncol Nurs. 2016 Nov/Dec;33(6):422-431. doi: 10.1177/1043454216655983. Epub 2016 Jul 9. J Pediatr Oncol Nurs. 2016. PMID: 27385664 Free PMC article.
-
Symptoms in Children Receiving Treatment for Cancer-Part II: Pain, Sadness, and Symptom Clusters.J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):262-279. doi: 10.1177/1043454219849578. J Pediatr Oncol Nurs. 2019. PMID: 31307323 Free PMC article. Review.
-
Development of risk-based guidelines for pediatric cancer survivors: the Children's Oncology Group Long-Term Follow-Up Guidelines from the Children's Oncology Group Late Effects Committee and Nursing Discipline.J Clin Oncol. 2004 Dec 15;22(24):4979-90. doi: 10.1200/JCO.2004.11.032. Epub 2004 Dec 2. J Clin Oncol. 2004. PMID: 15576413
-
Symptoms in Children Receiving Treatment for Cancer-Part I: Fatigue, Sleep Disturbance, and Nausea/Vomiting.J Pediatr Oncol Nurs. 2019 Jul/Aug;36(4):244-261. doi: 10.1177/1043454219849576. J Pediatr Oncol Nurs. 2019. PMID: 31307321 Free PMC article. Review.
Cited by
-
Profiles of Symptom Suffering and Functioning in Children and Adolescents Receiving Chemotherapy.Cancer Nurs. 2023 Mar-Apr 01;46(2):E129-E137. doi: 10.1097/NCC.0000000000001122. Epub 2022 Dec 11. Cancer Nurs. 2023. PMID: 35816032 Free PMC article.
-
Self-reported late effect symptom clusters among young pediatric cancer survivors.Support Care Cancer. 2021 Dec;29(12):8077-8087. doi: 10.1007/s00520-021-06332-4. Epub 2021 Jul 6. Support Care Cancer. 2021. PMID: 34228172
-
Feasibility and acceptability of a game-based symptom-reporting app for children with cancer: perspectives of children and parents.Support Care Cancer. 2021 Jan;29(1):301-310. doi: 10.1007/s00520-020-05495-w. Epub 2020 May 2. Support Care Cancer. 2021. PMID: 32358779 Free PMC article.
-
Prevalence of symptoms in children with acute lymphoblastic leukaemia: a systematic review and meta-analysis.BMC Cancer. 2023 Nov 15;23(1):1113. doi: 10.1186/s12885-023-11581-z. BMC Cancer. 2023. PMID: 37968600 Free PMC article.
-
Children's Oncology Group 2023 blueprint: Nursing discipline.Pediatr Blood Cancer. 2023 Sep;70 Suppl 6(Suppl 6):e30575. doi: 10.1002/pbc.30575. Epub 2023 Jul 20. Pediatr Blood Cancer. 2023. PMID: 37470719 Free PMC article.
References
-
- Baggott C., Dodd M., Kennedy C., Marina N., Matthay K. K., Cooper B. A., Miaskowski C. (2010). Changes in children’s reports of symptom occurrence and severity during a course of myelosuppressive chemotherapy. Journal of Pediatric Oncology Nursing, 27, 307-315. doi:10.1177/1043454210377619 - DOI - PubMed
-
- Basch E., Deal A. M., Dueck A. C., Scher H. I., Kris M. G., Hudis C., Schrag D. (2017). Overall survival results of a trial assessing patient-reported outcomes for symptom monitoring during routine cancer treatment. Journal of the American Medical Association, 318, 197-198. doi:10.1001/jama.2017.7156 - DOI - PMC - PubMed
-
- Graetz I., McKillop C. N., Stepanski E., Vidal G. A., Anderson J. N., Schwartzberg L. S. (2018). Use of a web-based app to improve breast cancer symptom management and adherence for aromatase inhibitors: A randomized controlled feasibility trial. Journal of Cancer Survivorship, 12, 431-440. doi:10.1007/s11764-018-0682-z - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical